Agenda

Articles

• FEDER
  16 March 2022, by Jonathan NOWAK

  Vect Horus a reçu l’accord de la Région Sud Provence-Alpes-Côte d’Azur, responsable de la mise en œuvre du dispositif REACT-EU dans le cadre du Programme Opérationnel FEDER-FSE, pour une subvention de 1 146 069 €.
  Vect-Horus développe sa plateforme technologique VECTrans® unique en Europe dont l’objectif est de développer des molécules « vecteurs » qui permettent le ciblage et la délivrance d’agents d’imagerie ou thérapeutiques dans des organes spécifiques. Cette stratégie est centrale, en (…)

• Meet Vect-Horus at OTS, Montreal, October 6-9, 2024
  2 October 2024, by Emmanuelle BETTENDORF

  Guillaume Jacquot and Emmanuelle Bettendorf will be representing Vect-Horus at the The Oligonucleotide Therapeutics Society (OTS) Annual Meeting, taking place in Montreal, Canada from October 6-9.
  This is the leading international meeting of renowned oligonucleotide scientists, bringing academia, research and business together, and we are excited to swap notes with other leading players in the field.
  👉 Click here for more on the meeting www.2024oligomeeting.com

• Meet Vect-Horus at BIOTECH SHOWCASE, San Francisco, January 8-10, 2024
  20 December 2023, by Emmanuelle BETTENDORF

  From January 8 to 10, Emmanuelle Bettendorf will participate in the #BiotechShowcase at #JPM24 and will be available to meet with you on partnership opportunities.

• Happy new year !
  2 January 2024, by Emmanuelle BETTENDORF

  The Vect-Horus teams join to wish you a Happy Holiday season and Best Wishes for 2024.

• Vect-Horus Nominated for the 2024 Biotech Trophy Award, Organized by France Biotech
  21 March 2024, by Emmanuelle BETTENDORF

  Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced it has been nominated for the 2024 Biotech Trophy award, organized by the France Biotech industry association.
  The award recognizes a biotech company which has distinguished itself in the past two years by particularly remarkable advances in R&D, operational development, partnerships or (…)

• Meet Vect-Horus at San Diego, California, June 3-6, 2024
  21 May 2024, by Emmanuelle BETTENDORF

  Next month, Emmanuelle Bettendorf will be attending the BIO International Convention, a major biotech industry conference taking place in San Diego, CA from June 3-6, 2024, and will be available to meet with you on partnership opportunities.
  Looking forward to seeing you there!

• Meet Vect-Horus at BIO International in Boston June 5-8, 2023
  5 June 2023, by Elodie DORMES

  Emmanuelle BETTENDORF, Sr Business Developer, will attend Bio International Convention.

• Meet Vect-Horus at the 36th PAMM-EORTC Winter meeting
  28 January 2019, by Jonathan NOWAK

  Pharmacology and Molecular Mechanisms Group (PAMM) of the European Organisation for Research and Treatment of Cancer (EORTC).
  Meet VECT-HORUS at the 36th PAMM-EORTC Winter meeting, Marseille, France
  January 21-24, 2015

• e-Meet Vect-Horus at the digital BIO International
  8 June 2020, by Elodie DORMES

  Elodie DORMES will be attending the digital BIO International convention in June 8-12, 2020

• e-Meet Vect-Horus at the digital BIO Europe Spring from March 28 to 31, 2022
  15 March 2022, by Elodie DORMES

  Emmanuelle BETTENDORF will participate in BioEurope Spring from March 28 to 31, 2022 and will be available to meet with you on partnership opportunities.